
PharmaSGP Holding SE
XETRA:PSG

Intrinsic Value
The intrinsic value of one
PSG
stock under the Base Case scenario is
40.85
EUR.
Compared to the current market price of 27.8 EUR,
PharmaSGP Holding SE
is
Undervalued by 32%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
PharmaSGP Holding SE
Fundamental Analysis


Revenue & Expenses Breakdown
PharmaSGP Holding SE
Balance Sheet Decomposition
PharmaSGP Holding SE
Current Assets | 67.5m |
Cash & Short-Term Investments | 37.8m |
Receivables | 16m |
Other Current Assets | 13.7m |
Non-Current Assets | 62.1m |
Long-Term Investments | 669k |
PP&E | 920k |
Intangibles | 60.5m |
Free Cash Flow Analysis
PharmaSGP Holding SE
EUR | |
Free Cash Flow | EUR |
Earnings Waterfall
PharmaSGP Holding SE
Revenue
|
114m
EUR
|
Cost of Revenue
|
-10.3m
EUR
|
Gross Profit
|
103.7m
EUR
|
Operating Expenses
|
-76.9m
EUR
|
Operating Income
|
26.8m
EUR
|
Other Expenses
|
-8m
EUR
|
Net Income
|
18.8m
EUR
|
PSG Profitability Score
Profitability Due Diligence
PharmaSGP Holding SE's profitability score is 65/100. The higher the profitability score, the more profitable the company is.

Score
PharmaSGP Holding SE's profitability score is 65/100. The higher the profitability score, the more profitable the company is.
PSG Solvency Score
Solvency Due Diligence
PharmaSGP Holding SE's solvency score is 50/100. The higher the solvency score, the more solvent the company is.

Score
PharmaSGP Holding SE's solvency score is 50/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
PSG Price Targets Summary
PharmaSGP Holding SE
According to Wall Street analysts, the average 1-year price target for
PSG
is 39.53 EUR
with a low forecast of 38.38 EUR and a high forecast of 41.48 EUR.
Dividends
Current shareholder yield for PSG is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
PSG
stock under the Base Case scenario is
40.85
EUR.
Compared to the current market price of 27.8 EUR,
PharmaSGP Holding SE
is
Undervalued by 32%.